FDA Cites Barr Seasonale TV Ad For Misleading Risk Information

The direct-to-consumer ad fails to reveal that patients may experience breakthrough bleeding or spotting for up to a year, an FDA ad division letter states. The agency also says the risk information contained in the ad is obscured by the "compelling visuals."